These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8036699

  • 1. Transplantation of a hepatitis B surface antigen-positive donor liver into a hepatitis B virus-negative recipient.
    González-Peralta RP, Andres JM, Tung FY, Fang JW, Brunson ME, Davis GL, Lau JY.
    Transplantation; 1994 Jul 15; 58(1):114-6. PubMed ID: 8036699
    [Abstract] [Full Text] [Related]

  • 2. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
    Donataccio D, Roggen F, De Reyck C, Verbaandert C, Bodeus M, Lerut J.
    Transpl Int; 2006 Jan 15; 19(1):38-43. PubMed ID: 16359375
    [Abstract] [Full Text] [Related]

  • 3. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, Geller SA, Nichols WS, Fong TL.
    Liver Transpl; 2001 Jun 15; 7(6):513-7. PubMed ID: 11443579
    [Abstract] [Full Text] [Related]

  • 4. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
    Abdelmalek MF, Pasha TM, Zein NN, Persing DH, Wiesner RH, Douglas DD.
    Liver Transpl; 2003 Dec 15; 9(12):1253-7. PubMed ID: 14625824
    [Abstract] [Full Text] [Related]

  • 5. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J.
    Liver Transpl; 2001 Jan 15; 7(1):51-8. PubMed ID: 11150423
    [Abstract] [Full Text] [Related]

  • 6. Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis.
    Cheung CK, Lo CM, Man K, Lau GK.
    Liver Transpl; 2010 Nov 15; 16(11):1314-23. PubMed ID: 21031547
    [Abstract] [Full Text] [Related]

  • 7. De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: analysis by determining complete sequence of the genome.
    Rokuhara A, Tanaka E, Yagi S, Mizokami M, Hashikura Y, Kawasaki S, Kiyosawa K.
    J Med Virol; 2000 Dec 15; 62(4):471-8. PubMed ID: 11074476
    [Abstract] [Full Text] [Related]

  • 8. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.
    Transplant Proc; 2005 Sep 15; 37(7):3045-7. PubMed ID: 16213299
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC, Yan LN, Li B, Wen TF, Zhao JC, Cheng NS, Liu C, Liu J, Wang XB, Li XD, Qin S, Zhao LS, Lei BJ, Zhang XH.
    Hepatobiliary Pancreat Dis Int; 2004 Feb 15; 3(1):26-32. PubMed ID: 14969833
    [Abstract] [Full Text] [Related]

  • 11. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L, Vargas V, Rodríguez F, Allende H, Buti M, Sánchez-Avila JF, Jardí R, Margarit C, Pumarola T, Esteban R, Guardia J.
    Liver Transpl; 2002 Oct 15; 8(10):892-900. PubMed ID: 12360430
    [Abstract] [Full Text] [Related]

  • 12. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V, Marzano A, Zamboni F, Barbui A, Franchello A, Gaia S, Marchiaro G, Salizzoni M, Rizzetto M.
    Liver Transpl; 2004 Mar 15; 10(3):356-62. PubMed ID: 15004761
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C, Koç H, Karayalcin S, Akyol G, Gürman G, Ilhan O, Akan H, Ozcan M, Arslan O, Konuk N, Uysal A, Beksaç M.
    Bone Marrow Transplant; 1997 Aug 15; 20(4):289-96. PubMed ID: 9285543
    [Abstract] [Full Text] [Related]

  • 14. Liver transplantation with allografts from hepatitis B core antibody-positive donors: a new approach.
    Fábrega E, García-Suarez C, Guerra A, Orive A, Casafont F, Crespo J, Pons-Romero F.
    Liver Transpl; 2003 Sep 15; 9(9):916-20. PubMed ID: 12942452
    [Abstract] [Full Text] [Related]

  • 15. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb 15; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

  • 16. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
    Fabrizio F, Bunnapradist S, Martin P.
    J Nephrol; 2002 Feb 15; 15(6):605-13. PubMed ID: 12495272
    [Abstract] [Full Text] [Related]

  • 17. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 15; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 18. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z, Mor E, Shapira Z, Tur-Kaspa R.
    Liver Transpl; 2001 Feb 15; 7(2):113-7. PubMed ID: 11172394
    [Abstract] [Full Text] [Related]

  • 19. Safe use of livers from donors with positive hepatitis B core antibody.
    Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ.
    Liver Transpl; 2002 Jun 15; 8(6):556-61. PubMed ID: 12037788
    [Abstract] [Full Text] [Related]

  • 20. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
    Datta S, Banerjee A, Chandra PK, Chowdhury A, Chakravarty R.
    J Med Virol; 2006 Jan 15; 78(1):53-9. PubMed ID: 16299727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.